Epigenetic Therapies and Potential Drugs for Treating Human Cancer.

Abstract:

:Epigenetic modifications ensure the maintenance of normal cellular functions, and their dysregulation is frequently found in many disease states, including cancer. Nowadays, the most studied epigenetic dysregulation associated with tumorigenesis, cancer progression and metastasis refers to the variations in DNA methylation, histone modification and chromatin structure. The development of novel agents targeting these processes has enabled us to open up new pathways for anti-cancer strategies. To date, many small molecules have been designed to target epigenetic modifiers, and some of them are currently in clinical trials for patients with haematologic malignancies and solid tumours. With this in mind, we elaborate on basic information on epigenetic modifications and potential epigenetic therapies for cancer treatment.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Lin SQ,Li X

doi

10.2174/1389450121666200325093104

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

1068-1083

issue

11

eissn

1389-4501

issn

1873-5592

pii

CDT-EPUB-105470

journal_volume

21

pub_type

杂志文章
  • Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfuntion.

    abstract::Flavonoids are chromene analogues abundantly found in plants. It is always of curiosity to discover natural flavonoid structures, since living things, including human, are routinely exposed to these compounds through many dietaries. Indeed, numerous studies conducted so far on flavonoids to display their diverse biolo...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450122666210120144921

    authors: Gulcan HO,Orhan IE

    更新日期:2021-01-20 00:00:00

  • Pro-oxidant natural products as anticancer agents.

    abstract::Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively targ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012802009044

    authors: Martin-Cordero C,Leon-Gonzalez AJ,Calderon-Montano JM,Burgos-Moron E,Lopez-Lazaro M

    更新日期:2012-07-01 00:00:00

  • Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect.

    abstract::The incidence and mortality of malignant tumors are on the rise, which has become the second leading cause of death in the world. At present, anti-tumor drugs are one of the most common methods for treating cancer. In recent years, with the in-depth study of tumor biology and related disciplines, it has been gradually...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666190402145325

    authors: Wang S,Zhou D,Xu Z,Song J,Qian X,Lv X,Luan J

    更新日期:2019-01-01 00:00:00

  • Ubiquitin and Ubiquitin-like proteins in cardiac disease and protection.

    abstract::Post-translational modification represents an important mechanism to regulate protein function in cardiac cells. Ubiquitin (Ub) and ubiquitin-like proteins (UBLs) are a family of protein modifiers that share a certain extent of sequence and structure similarity. Conjugation of Ub or UBLs to target proteins is dynamica...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666151209114608

    authors: Li J,Johnson JA,Su H

    更新日期:2018-01-01 00:00:00

  • Urinary Bone Turnover Markers as Target Indicators for Monitoring Bisphosphonate Drug Treatment in the Management of Osteoporosis.

    abstract:BACKGROUND:Osteoporosis is a debilitating disease characterized by bone micro-architecture degradation contributing to fragility fractures. Currently, determining bone mineral density (BMD) via dual-energy X-ray absorptiometry (DXA) is the most reliable form of diagnosing osteoporosis and managing pharmacological treat...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450118666170704143529

    authors: Kwon S,Wang AH,Sadowski CA,Yuksel N,Doschak MR

    更新日期:2018-01-01 00:00:00

  • Sphingolipid metabolism enzymes as targets for anticancer therapy.

    abstract::Treatment with anti-cancer agents in most cases ultimately results in apoptotic cell death of the target tumor cells. Unfortunately, tumor cells can develop multidrug resistance, e.g., by a reduced propensity to engage in apoptosis by which they become insensitive to multiple chemotherapeutics. Ceramide. the central m...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043345452

    authors: Kok JW,Sietsma H

    更新日期:2004-05-01 00:00:00

  • Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia.

    abstract:BACKGROUND:Preeclampsia, a gestational disease characterized by hypertension and proteinuria twenty weeks into pregnancy, is one of the leading causes of fetal and maternal mortality. Although multiple genetic and environmental factors are found to be related to the preeclampsia risk, the pathogenic pathways remain lar...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450118666170404160000

    authors: Song X,Luo X,Gao Q,Wang Y,Gao Q,Long W

    更新日期:2017-01-01 00:00:00

  • Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.

    abstract::Cardiovascular diseases (CVD) are the leading cause of death, chronic illness and disability in Western countries. The most common cause of CVD derives from the harmful effects of acute myocardial ischemia and subsequent reperfusion injury. Cardioprotection against acute ischemia/ reperfusion injury is made possible b...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150309115536

    authors: Penna C,Granata R,Tocchetti CG,Gallo MP,Alloatti G,Pagliaro P

    更新日期:2015-01-01 00:00:00

  • Antiphospholipid syndrome: characteristics and obstetrical management.

    abstract::Antiphospholipid syndrome (APS) is characterized by a combination of clinical features consisted of thrombotic or pregnancy-related events and autoimmune antiphospholipid antibodies. In the 1998 International Consensus Preliminary Criteria, APS is defined by the concomitant presence of these clinical features and labo...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450054545999

    authors: Nishiguchi T,Kobayashi T

    更新日期:2005-08-01 00:00:00

  • Targeting PPAR isoforms following CNS injury.

    abstract::A major focus has developed for the discovery of proregenerative and neuroprotective therapeutic agents to help the millions of Americans who receive a CNS injury annually. Tribulations have been encountered along the way due to the complicated set of pathways that are initiated post-injury. To target this complicated...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314070003

    authors: Yonutas HM,Sullivan PG

    更新日期:2013-06-01 00:00:00

  • Metal and inflammatory targets for Alzheimer's disease.

    abstract::Alzheimer's disease (AD) has become linked to inflammation and metal biology. Metals (copper, zinc and iron) and inflammatory cytokines are significant factors that increase the onset of sporadic late onset forms of the dementia. The genetic discovery that alleles in the hemochromatosis gene accelerate the onset of di...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043345272

    authors: Rogers JT,Lahiri DK

    更新日期:2004-08-01 00:00:00

  • Targeting the RAS signaling pathway in malignant hematologic diseases.

    abstract::Molecularly targeting signaling pathways that are involved in the pathogenesis of hematopoietic malignancies may lead to more specific and efficacious therapies. Activation of the RAS signal transduction cascade is a common feature in the molecular pathogenesis of hematologic malignancies. A number of novel agents tar...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007779940043

    authors: Morgan MA,Ganser A,Reuter CW

    更新日期:2007-02-01 00:00:00

  • Insight into Pain Modulation: Nociceptors Sensitization and Therapeutic Targets.

    abstract::Pain is a complex multidimensional concept that facilitates the initiation of the signaling cascade in response to any noxious stimuli. Action potential generation in the peripheral nociceptor terminal and its transmission through various types of nociceptors corresponding to mechanical, chemical or thermal stimuli le...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666190131114244

    authors: Khan A,Khan S,Kim YS

    更新日期:2019-01-01 00:00:00

  • Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.

    abstract::Resveratrol (3,4',5 tri-hydroxystilbene) is a phytoalexin produced in hudge amount in grapevine skin in response to infection by Bothrytis cinerea. This production of resveratrol blocks the proliferation of the pathogen, thereby acting as a natural antibiotic. Numerous studies have reported interesting properties of t...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006776359331

    authors: Delmas D,Lançon A,Colin D,Jannin B,Latruffe N

    更新日期:2006-04-01 00:00:00

  • Reducing the risk of major elective non-cardiac surgery: is there a role for levosimendan in the preoperative optimization of cardiac function?

    abstract::Patients with heart failure undergoing non-cardiac surgery still have an unacceptably high morbidity and mortality. Compromised myocardial physiologic reserves in combination with extensive surgery and anesthesia appear to play a crucial role in determining high perioperative morbidity and mortality. Nevertheless, sev...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/138945009789108819

    authors: Morelli A,Ertmer C,Pietropaoli P,Westphal M

    更新日期:2009-09-01 00:00:00

  • Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer.

    abstract::Overexpression of the human epidermal growth factor receptor 2 (HER2) is identified in approximately 25- 30% of breast cancers and indicates a poor prognosis. Trastuzumab, the anti-HER2 monoclonal antibody (mAb), has shown significant clinical effects selectively in HER2-overexpressing metastatic breast cancer (MBC) w...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990161

    authors: Huang Y,Fu P,Fan W

    更新日期:2013-07-01 00:00:00

  • Accuracy of 25-hydroxyvitamin D assays: confronting the issues.

    abstract::Measurement of 25-hydroxyvitamin D (25-OHD) is widely used for assessing vitamin D status. There has been a dramatic increase in 25-OHD requests over recent years prompting many laboratories to consider the use of automated immunoassays. To achieve higher throughput, these methods have abandoned the traditional solven...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011793591608

    authors: Carter GD

    更新日期:2011-01-01 00:00:00

  • Fetal determinants of type 2 diabetes.

    abstract::Type 2 diabetes, which has dramatically increased during the last decade normally results from a combination of pancreatic beta cell dysfunction and insulin resistance. One of the most recent risk factors identified for type 2 diabetes is a sub-optimal fetal and neonatal environment. Numerous human epidemiological stu...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007781386866

    authors: Reusens B,Ozanne SE,Remacle C

    更新日期:2007-08-01 00:00:00

  • Withdrawn: Stem Cell Transplant from Unrelated Donor in Patients with Severe Aplastic Anemia: Indications, Donor Selection, Conditioning, GVHD Prophylaxis.

    abstract::Withdrawn by the publisher. ...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:

    authors:

    更新日期:2015-02-12 00:00:00

  • A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin.

    abstract:BACKGROUND:The plant milk thistle and silymarin has been traditionally used as a natural remedy for the treatment of various ailments including neurological disorders such as Alzheimer's and Parkinson's disease and cerebral ischemia for over 2000 years. OBJECTIVE:In this article we review the neuroprotective effects o...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666161227125121

    authors: Devi KP,Malar DS,Braidy N,Nabavi SM,Nabavi SF

    更新日期:2017-01-01 00:00:00

  • Nutrition in adult patients with inflammatory bowel disease.

    abstract::Seventy five percent of hospitalized patients with Crohn's disease suffer from malnutrition. One third of Crohn's disease patients have a body mass index below 20. Sixty percent of Crohn's disease patients have sarcopenia. However some inflammatory bowel disease (IBD) patients are obese or suffer from sarcopenic-obesi...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450115666140930150047

    authors: Hebuterne X,Filippi J,Schneider SM

    更新日期:2014-01-01 00:00:00

  • Gene therapy for arthritis.

    abstract::Recent progress in molecular biology has provided application of gene transfer methods in arthritis. Two clinical trails using ex vivo retrovirus mediated delivery of interleukin -1 receptor antagonist gene for rheumatoid arthritis has begun in USA and Germany. However, there are still many issues to be elucidated; on...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450033490777

    authors: Tomita T,Hashimoto H,Yoshikawa H

    更新日期:2003-11-01 00:00:00

  • EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer.

    abstract::Lung cancer kills approximately 1.3 million citizens in the world annually. The tyrosine kinase inhibitors (TKI) erlotinib and gefitinib are effective anti-tumor agents especially in lung cancer patients with epidermal growth factor receptor (EGFR) mutations. The goal is to increase the potency of TKI in lung cancer p...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150107153609

    authors: Moody TW,Nuche-Berenguer B,Nakamura T,Jensen RT

    更新日期:2016-01-01 00:00:00

  • Metabolic syndrome as a modifier of atherosclerosis in murine models.

    abstract::The Metabolic Syndrome is a common metabolic disease associated with an increased risk for atherosclerotic cardiovascular disease and mortality. In contrast to "traditional" risk factors for atherosclerosis, such as low-density lipoprotein cholesterol, the Metabolic Syndrome represents a network of interacting risk fa...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007782403838

    authors: Péterfy M,Davis RC,Lusis AJ

    更新日期:2007-11-01 00:00:00

  • Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors.

    abstract::Family C of G-protein coupled receptors (GPCRs) from humans is constituted by eight metabotropic glutamate (mGlu(1-8)) receptors, two heterodimeric gamma-aminobutyric acid(B) (GABA(B)) receptors, a calcium-sensing receptor (CaR), three taste (T1R) receptors, a promiscuous L-alpha-amino acid receptor (GPRC6A), and five...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007779315614

    authors: Bräuner-Osborne H,Wellendorph P,Jensen AA

    更新日期:2007-01-01 00:00:00

  • Pancreatic Neoplasms and Autophagy.

    abstract::Pancreatic cancer is predicted to be the second deadliest malignancy (a median survival of 4-6 months and a 5-year survival of less than 5%) in the USA by 2020. Although current medical detection technologies have dramatically improved the survival rate for patients with other gastrointestinal malignancies, the dismal...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160622220915

    authors: Barton LA,Ren J

    更新日期:2018-01-01 00:00:00

  • Raloxifene.

    abstract::Efforts to interfere with the initiation and promotion of breast and other cancers by endocrine manipulation are not new. It is of obvious benefit to cancer patients to administer substances that combine minimal general toxicity with maximal oestrogen inhibition. Raloxifene is a relatively recent addition to a group o...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450013348263

    authors: Kellen JA

    更新日期:2001-12-01 00:00:00

  • Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation.

    abstract::Inflammation plays a central role in chronic obstructive pulmonary disease (COPD). COPD related inflammation is less responsive to inhaled steroids compared to asthma. There are three major novel anti-inflammatory approaches to the management of COPD. The first approach is phosphodiesterase inhibitors, such as roflumi...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314020008

    authors: Loukides S,Bartziokas K,Vestbo J,Singh D

    更新日期:2013-02-01 00:00:00

  • Genomic databases and the search of protein targets for protozoan parasites.

    abstract::The development of databases devoted to biological information opened the possibility to integrate, query and analyze biological data obtained from several sources that otherwise would be scattered through the web. Several issues arise in the handling of biological information, mainly due to the diversity of biologica...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787581195

    authors: Timmers LF,Pauli I,Barcellos GB,Rocha KB,Caceres RA,de Azevedo WF Jr,Soares MB

    更新日期:2009-03-01 00:00:00

  • An Overview of Prospective Drugs for Type 1 and Type 2 Diabetes.

    abstract:AIMS:The aim of this study is to provide an overview of several emerging anti-diabetic molecules. BACKGROUND:Diabetes is a complex metabolic disorder involving the dysregulation of glucose homeostasis at various levels. Insulin, which is produced by β-pancreatic cells, is a chief regulator of glucose metabolism, regul...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450120666191031104653

    authors: Wu P,Liu Z,Jiang X,Fang H

    更新日期:2020-01-01 00:00:00